Peripheral: Research Studies

24 Related Result(s)

1. A Randomized, Phase III Study Comparing Conventional Dose Treatment Using a Combination of Lenalidomide, Bortezomib and Dexamethasone (RVD) to High-Dose Treatment with Peripheral Stem Cell Transplant in the Initial Management of Myeloma in Patients up to 65 Years of Age

   The purpose of this study is to explore the drug combination, lenalidomide, bortezomib and dexamethasone alone or when combined with autologous stem cell...

2. Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)

   To centrally genotype resected lung adenocarcinomas for EGFR mutations and ALK rearrangements to facilitate accrual to randomized adjuvant studies. To obtain...

3. Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial

   This randomized phase III trial studies how well aspirin works in preventing the cancer from coming back (recurrence) in patients with human epidermal growth...

4. Beat AML: Personalized Medicine for Acute Myeloid Leukemia Based on Functional Genomics

   In this study, DNA sequencing, computational biology modeling, and ex vivo drug sensitivity assays will be utilized to define clinically relevant gene...

5. DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors

   This clinical trial studies nivolumab and ipilimumab in treating patients with rare tumors. Monoclonal antibodies, such as nivolumab and ipilimumab, may...

6. Dopamine transmission in peripheral immune cells of patients with Parkinson's disease

   The purpose of this research is to collect blood from Parkinson’s disease patients and healthy individuals, as well as patients with major depressive...

7. Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma

   The purpose of this study is to look at late effects after treatment in patients with previously diagnosed high-risk neuroblastoma. Studying late...

8. NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol

   This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients...

9. Open Label Phase 2 Study of Tisotumab Vedotin for Locally Advanced or Metastatic Disease in Solid Tumors

   Evaluate antitumor activity of tisotumab vedotin as measured by investigator-determined confirmed objective response rate using Response Evaluation Criteria...

10. Optimizing Cord Blood and Haploidentical Aplastic Anemia Transplantation (CHAMP) (BMT CTN #1502)

    Acquired SAA is a rare bone marrow failure disorder with an estimated annual incidence of 2 cases per million and with over 600 new cases in the United...

Pages